PD-L1 Boosts MET Phosphorylation, Promotes Osimertinib Resistance
In a groundbreaking study, researchers have elucidated the complex interplay between PD-L1 and c-MET, revealing significant insights that could alter ...
In a groundbreaking study, researchers have elucidated the complex interplay between PD-L1 and c-MET, revealing significant insights that could alter ...
In the evolving field of perioperative oncology, a recent study spearheaded by researchers Huang, HY., Han, YJ., and Tang, Y. ...
In a groundbreaking development that could reshape the landscape of lung cancer treatment, scientists have unveiled a novel mechanism by ...
In the ever-evolving landscape of cancer immunotherapy, one of the most formidable challenges remains the innate resistance some tumors exhibit ...
Recent advancements in cancer therapeutics have brought to light an extraordinary small molecule, identified as the 3,4-diisobutyryl derivative of auxarthrol ...
Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant NSCLC: Unraveling the Complex Landscape of Therapeutic Evasion In the relentless battle ...
In the relentless pursuit of innovative cancer therapies, scientific researchers are increasingly turning their attention to molecular pathways that govern ...
In a groundbreaking study published in the Journal of Translational Medicine, researchers have unveiled the potential of Ginsenoside Rh2 as ...
In recent years, the landscape of cancer treatment has been dramatically transformed by immunotherapy, offering new hope to patients with ...
In recent years, the landscape of non-small cell lung cancer (NSCLC) treatment has undergone a significant transformation, driven primarily by ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine